• Home
  • News
  • Fortune 500
  • Tech
  • Finance
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
China

Here’s why investors are piling into baby stocks in China

By
Jonathan Chew
Jonathan Chew
By
Jonathan Chew
Jonathan Chew
October 30, 2015, 8:47 AM ET
A young boy is held by his grandfather on a path in Beijing on October 30, 2015.
A young boy is held by his grandfather on a path in Beijing on October 30, 2015. China announced the end of its hugely controversial one-child policy on October 29, after decades of strict, sometimes brutal enforcement left it with an ageing population and shrinking workforce, heightening the challenges of slowing growth. AFP PHOTO / GREG BAKER (Photo credit should read GREG BAKER/AFP/Getty Images)Photograph by Greg Baker — AFP/Getty Images

China’s decision to end its one-child policy after 35 years has created a whole new class of baby boomers in the stock market.

Stocks in baby-related companies, from infant formula to strollers, have been spiking since the Communist Party raised its population control ceiling to two kids per family, a move to combat an aging workforce amidst a slowing economy.

Analysts at investment bank Credit Suisse estimated that the new ruling could lead to six million more babies born annually in the five-year period starting in 2017, and that means more products would be needed to sustain these added baby steps. Among the stock market’s biggest growth spurts: infant formula maker Biostime International rose around 15% on the Hong Kong stock exchange, while China Child Care Corp, which makes hair and skin care for kids, saw stocks rise by 33%.

Other winners include infant formula company Yashili International (up 7.7%), education services provider Shanghai Xin Nanyang (up 10%) and stroller manufacturer Goodbaby International (up 6.3%).

However, some investors are cautioning against joining the crowd. On news that shares in Mead Johnson—kids nutrition giant and owner of the popular infant formula brand Enfamil—have risen 3.8%, Nomura equity analyst David Hayes wrote in a note to clients that:

With MJN deriving c 50% of its profit from China/HK infant formula, the stock is likely to react strongly to these headlines. On a (very) simplistic basis, correlating the Danone move, the stock could be up a double-digit percentage. A significant uplift in the share price of China baby food exposed stocks is though, in our view, an overreaction. The market has in the past had a tendency to become overly excited about the implications on the policy relaxation in China, and we have seen a more balanced/better informed adjustment take place over the preceding few days/weeks.

There have been losers in the aftermath of China’s policy change, however. Shares in Japanese condom maker Okamoto Industries have fallen by 5% on the Tokyo stock exchange since news broke.

About the Author
By Jonathan Chew
See full bioRight Arrow Button Icon
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Leadership
  • Success
  • Tech
  • Asia
  • Europe
  • Environment
  • Fortune Crypto
  • Health
  • Retail
  • Lifestyle
  • Politics
  • Newsletters
  • Magazine
  • Features
  • Commentary
  • Mpw
  • CEO Initiative
  • Conferences
  • Personal Finance
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map

© 2025 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.